LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM
Approval overview LEUCOVORIN CALCIUM is listed in Drugs@FDA under application 207241 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LEUCOVORIN CALCIUM Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - EQ 100MG BASE/10ML (EQ 10MG BASE/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2018-03-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview LEUCOVORIN CALCIUM is listed in Drugs@FDA under application 207241 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEUCOVORIN CALCIUM Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - EQ 100MG BASE/10ML (EQ 10MG BASE/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2018-03-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.